SCHEMBL4746545

SCHEMBL4746545

CC(C)c1cc2c(c(N3CCN(C(=O)C=Cc4ccc(O)cc4)CC3)n1)C(=O)OCC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ME2 P23368 1/20 0.44
ME1 P48163 1/20 0.44
ME3 Q16798 1/20 0.44
ESR1 P03372 5/20 0.42
ESR2 Q92731 5/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
GPR183 P32249 3/20 0.41
ALDH1A1 P00352 2/20 0.41
POLB P06746 2/20 0.41
KDM4E B2RXH2 1/20 0.41
CCR4 P51679 1/20 0.40
MAPT P10636 3/20 0.39
HPGD P15428 3/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4749902 0.91 GPR183 (0.53) NPC1RAB9AGPR183ALDH1A1MAPT
SCHEMBL4747137 0.88 L3MBTL1 (0.53) ALDH1A1KDM4EHPGDLMNAMEN1
SCHEMBL4749260 0.88 CCNC (0.38) NPC1RAB9AALDH1A1POLBKDM4E
SCHEMBL4817000 0.86 ME2 (0.44) ME2ME1ME3ESR1ESR2
SCHEMBL4750248 0.85 LMNA (0.47) ALDH1A1POLBKDM4EHPGDLMNA
SCHEMBL4747050 0.84 KDM4E (0.52) NPC1RAB9AALDH1A1KDM4EMAPT
SCHEMBL4749877 0.81 KDM4E (0.46) NPC1RAB9AGPR183ALDH1A1KDM4E
SCHEMBL4749965 0.78 KDM4E (0.43) ALDH1A1POLBKDM4EHPGDMEN1
SCHEMBL4749923 0.76 KDM4E (0.44) ALDH1A1POLBKDM4EMAPTHPGD
SCHEMBL4749360 0.75 ALDH1A1 (0.55) ALDH1A1POLBKDM4EHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008123756-A1 A PHARMACEUTICAL COMPOSITIONS CONTAINING LACTON TYPE PYRIDINE DERIVATIVES AS AN EFFECTIVE INGREDIENT FOR THE PREVENTION AND TREATMENT OF ISCHEMIA SK CHEMICALS CO., LTD. (KR) 2008-10-16 WO claimed
WO-2008123756-A1 A PHARMACEUTICAL COMPOSITIONS CONTAINING LACTON TYPE PYRIDINE DERIVATIVES AS AN EFFECTIVE INGREDIENT FOR THE PREVENTION AND TREATMENT OF ISCHEMIA SK CHEMICALS CO., LTD. (KR) 2008-10-16 WO disclosed